Abstract: Provided are a class of alkylphenol compounds and a preparation method therefor. Specifically provided are a new alkyl polyphenol compound as represented by chemical formula I, and a preparation method therefor and the use thereof in the treatment of metabolic syndrome.

Abstract: A data processing method for a convolutional neural network includes: (a) obtaining a matrix parameter of an eigenmatrix; (b) reading corresponding data in an image data matrix from a first buffer space based on the matrix parameter through a first bus, to obtain a next to-be-expanded data matrix, and sending and storing the to-be-expanded data matrix to a second preset buffer space through a second bus; (c) reading the to-be-expanded data matrix, and performing data expansion on the to-be-expanded data matrix to obtain expanded data; (d) reading a preset number of pieces of unexpanded data in the image data matrix, sending and storing the unexpanded data to the second preset buffer space, and updating, based on the unexpanded data, the to-be-expanded data matrix; and (e). repeating (c) and (d) until all data in the image data matrix is completely read out on the to-be-expanded data matrix.

Abstract: Embodiments of this application provide a convolution operation processing method and a related product. The integrated chip includes a control unit, at least one convolutional processing element, an input cache, and an output cache. The control unit loads a sectioned convolution kernel and sectioned convolution input data into the input cache, the sectioned convolution kernel being generated by sectioning a convolution kernel and including a plurality of convolution kernel segments, and the sectioned convolution input data being generated by sectioning convolution input data and including a plurality of convolution input data segments; and the at least one convolutional processing element performs a sectioned convolution operation on the sectioned convolution kernel and the sectioned convolution input data to obtain a sectioned convolution result, and stores the sectioned convolution result into the output cache.

Abstract: A data processing method for a convolutional neural network includes: (a) obtaining a matrix parameter of an eigenmatrix; (b) reading corresponding data in an image data matrix from a first buffer space based on the matrix parameter through a first bus, to obtain a next to-be-expanded data matrix, and sending and storing the to-be-expanded data matrix to a second preset buffer space through a second bus; (c) reading the to-be-expanded data matrix, and performing data expansion on the to-be-expanded data matrix to obtain expanded data; (d) reading a preset number of pieces of unexpanded data in the image data matrix, sending and storing the unexpanded data to the second preset buffer space, and updating, based on the unexpanded data, the to-be-expanded data matrix; and (e). repeating (c) and (d) until all data in the image data matrix is completely read out on the to-be-expanded data matrix.

Abstract: A data processing method for a convolutional neural network includes: (a) obtaining a matrix parameter of an eigenmatrix; (b) reading corresponding data in an image data matrix from a first buffer space based on the matrix parameter through a first bus, to obtain a next to-be-expanded data matrix, and sending and storing the to-be-expanded data matrix to a second preset buffer space through a second bus; (c) reading the to-be-expanded data matrix, and performing data expansion on the to-be-expanded data matrix to obtain expanded data; (d) reading a preset number of pieces of unexpanded data in the image data matrix, sending and storing the unexpanded data to the second preset buffer space, and updating, based on the unexpanded data, the to-be-expanded data matrix; and (e). repeating (c) and (d) until all data in the image data matrix is completely read out on the to-be-expanded data matrix.

Abstract: Disclosed are a pentacyclic triterpene compound as shown in general formula (I) and a preparation method therefor. The compound has an effective antagonistic effect on FXR receptors.

Abstract: The invention describes an aryl-2,2?-tandem bisthiazole compound and a preparation method and the use thereof. In particular, disclosed in the present invention are an aryl-2,2?-tandem bisthiazole compound with the structure as shown in general formula I and the preparation method thereof and use thereof as a histone deacetylase inhibitor in the preparation of antitumor drugs.

Abstract: Disclosed are a pentacyclic triterpene compound as shown in general formula (I) and a preparation method therefor. The compound has an effective antagonistic effect on FXR receptors.

Abstract: Embodiments of this application provide a convolution operation processing method and a related product. The integrated chip includes a control unit, at least one convolutional processing element, an input cache, and an output cache. The control unit loads a sectioned convolution kernel and sectioned convolution input data into the input cache, the sectioned convolution kernel being generated by sectioning a convolution kernel and including a plurality of convolution kernel segments, and the sectioned convolution input data being generated by sectioning convolution input data and including a plurality of convolution input data segments; and the at least one convolutional processing element performs a sectioned convolution operation on the sectioned convolution kernel and the sectioned convolution input data to obtain a sectioned convolution result, and stores the sectioned convolution result into the output cache.

Abstract: The invention describes an aryl-2,2?-tandem bisthiazole compound and a preparation method and the use thereof. In particular, disclosed in the present invention are an aryl-2,2?-tandem bisthiazole compound with the structure as shown in general formula I and the preparation method thereof and use thereof as a histone deacetylase inhibitor in the preparation of antitumor drugs.

Abstract: The present invention provides a compound represented by general formula I or a pharmaceutical acceptable salt thereof, the preparation method therefor and the use thereof in preparing a medicine for treating a neurological disease, such as epilepsy, convulsion, neuropathic pain, acute ischemic stroke, and a neurodegenerative disease. The compound according to present invention has a better absorption in brain tissue when compared with RTG. In addition, the compound provided by present invention has not only a greatly enhanced efficacy, but also a neurotoxicity greatly lower than that of RTG, and thus possesses a wider safety window.

Abstract: A data processing method for a convolutional neural network includes: (a) obtaining a matrix parameter of an eigenmatrix; (b) reading corresponding data in an image data matrix from a first buffer space based on the matrix parameter through a first bus, to obtain a next to-be-expanded data matrix, and sending and storing the to-be-expanded data matrix to a second preset buffer space through a second bus; (c) reading the to-be-expanded data matrix, and performing data expansion on the to-be-expanded data matrix to obtain expanded data; (d) reading a preset number of pieces of unexpanded data in the image data matrix, sending and storing the unexpanded data to the second preset buffer space, and updating, based on the unexpanded data, the to-be-expanded data matrix; and (e). repeating (c) and (d) until all data in the image data matrix is completely read out on the to-be-expanded data matrix.

Abstract: The present invention relates to a series of analogs of natural product Pyripyropene A represented by general formula I and a preparation method and use thereof. More particularly, the present invention relates to analogs of the natural product Pyripyropene A, a preparation method and use thereof as the acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors for the treatment of cardiovascular diseases such as atherosclerosis and the like.

Abstract: The present invention provides a compound represented by general formula I or a pharmaceutical acceptable salt thereof, the preparation method therefor and the use thereof in preparing a medicine for treating a neurological disease, such as epilepsy, convulsion, neuropathic pain, acute ischemic stroke, and a neurodegenerative disease. The compound according to present invention has a better absorption in brain tissue when compared with RTG. In addition, the compound provided by present invention has not only a greatly enhanced efficacy, but also a neurotoxicity greatly lower than that of RTG, and thus possesses a wider safety window.

Abstract: The present invention provides a compound represented by general formula I or a pharmaceutical acceptable salt thereof, the preparation method therefor and the use thereof in preparing a medicine for treating a neurological disease, such as epilepsy, convulsion, neuropathic pain, acute ischemic stroke, and a neurodegenerative disease. The compound according to present invention has a better absorption in brain tissue when compared with RTG. In addition, the compound provided by present invention has not only a greatly enhanced efficacy, but also a neurotoxicity greatly lower than that of RTG, and thus possesses a wider safety window.

Abstract: The present invention relates to a series of analogues of natural product Pyripyropene A represented by general formula I and a preparation method and use thereof. More particularly, the present invention relates to analogues of the natural product Pyripyropene A, a preparation method and use thereof as the acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors for the treatment of cardiovascular diseases such as atherosclerosis and the like.

Abstract: The present invention relates to a thiazole-based compound, a preparation method therefor, and a use thereof. More specifically, the present invention relates to a 2,2?-bis-thiazole-based compound, a preparation method therefor, and a use of 2,2?-bis-thiazole-based compound a histone deacetylase inhibitor in the preparation of an antitumor medicament, a medicament for treating autoimmune diseases, a medicament for treating type II diabetes mellitus and complication thereof, or a medicament for treating neurodegenerative diseases.

Abstract: The present invention provides a compound represented by general formula I or a pharmaceutical acceptable salt thereof, the preparation method therefor and the use thereof in preparing a medicine for treating a neurological disease, such as epilepsy, convulsion, neuropathic pain, acute ischemic stroke, and a neurodegenerative disease. The compound according to present invention has a better absorption in brain tissue when compared with RTG. In addition, the compound provided by present invention has not only a greatly enhanced efficacy, but also a neurotoxicity greatly lower than that of RTG, and thus possesses a wider safety window.

Abstract: The present invention relates to a thiazole-based compound, a preparation method therefor, and a use thereof. More specifically, the present invention relates to a 2,2?-bis-thiazole-based compound, a preparation method therefor, and a use of 2,2?-bis-thiazole-based compound a histone deacetylase inhibitor in the preparation of an antitumor medicament, a medicament for treating autoimmune diseases, a medicament for treating type II diabetes mellitus and complication thereof, or a medicament for treating neurodegenerative diseases.

Abstract: The present invention provides compounds having the structure represented by general formula I, pharmaceutically acceptable salts thereofagonist, preparation methods therefor and a use thereof in the preparation of a medicine for the treatment of nervous system diseases. The compounds or pharmaceutical compositions thereof can be used as the KCNQ potassium channel agonist for treating nervous system diseases. Compared to retigabine, a compound in the prior art, the compound of the present invention have the same or better therapeutic effect, are easier for synthesis and storage, and less prone to oxidate deterioration.